GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Scienture Holdings Inc (NAS:SCNX) » Definitions » Forward PE Ratio

SCNX (Scienture Holdings) Forward PE Ratio : 0.00 (As of Apr. 11, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Scienture Holdings Forward PE Ratio?

Scienture Holdings's Forward PE Ratio for today is 0.00.

Scienture Holdings's PE Ratio without NRI for today is 0.00.

Scienture Holdings's PE Ratio (TTM) for today is 0.06.


Scienture Holdings Forward PE Ratio Historical Data

The historical data trend for Scienture Holdings's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scienture Holdings Forward PE Ratio Chart

Scienture Holdings Annual Data
Trend 2020-12
Forward PE Ratio
17.64

Scienture Holdings Quarterly Data
2020-06 2020-09 2020-12
Forward PE Ratio 47.85 16.39 17.64

Competitive Comparison of Scienture Holdings's Forward PE Ratio

For the Pharmaceutical Retailers subindustry, Scienture Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scienture Holdings's Forward PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Scienture Holdings's Forward PE Ratio falls into.


;
;

Scienture Holdings Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Scienture Holdings  (NAS:SCNX) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Scienture Holdings Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Scienture Holdings's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Scienture Holdings Business Description

Traded in Other Exchanges
Address
2420 Brunello Trace, Lutz, FL, USA, 33558
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.
Executives
A. Jeffrey Newell director 645 CAMP DIXIE RD, PASCOAG RI 02859
Donald G. Fell director 17537 DARBY LANE, LUTZ FL 33558
Janet Huffman officer: CFO, PAO, PFO 5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232
Michael L Peterson director 17 CANARY COURT, DANVILLE CA 94526
Christine L. Jennings director 3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639
Prashant Patel director, 10 percent owner, officer: President 17537 DARBY LANE, LUTZ FL 33558
Pamela Tenaerts director PO BOX 15012, SARASOTA FL 34277
Gary Augusta director 700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203
Howard A. Doss officer: CFO 17537 DARBY LANE, LUTZ FL 90067
Surendra K Ajjarapu director, 10 percent owner, officer: CEO 8604 BUTTON BUSH CT, TAMPA FL 33647
Donald V. Almeida director 1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556
Charles L Pope director 4902 EISENHOWER BOULEVARD, TAMPA FL 33634
Sandhya Ajjarapu 10 percent owner 17537 DARBY LANE, LUTZ FL 33558